期刊文献+

二甲双胍和胰高糖素样多肽-1对2型糖尿病患者并发骨折恢复的影响 被引量:5

Effects of metformin and glucagon like polypeptide-1 on fracture recovery in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨二甲双胍和胰高糖素样多肽-1对2型糖尿病患者并发骨折恢复的影响。方法选取2016年5月—2017年4月我院骨科收治的2型糖尿病并发骨折患者120例,按随机原则分为5组,每组24例,单药低剂量二甲双胍组(A1)、单药高剂量二甲双胍组(A2)、单药GLP-1组(B)、低剂量二甲双胍联合GLP-1组(C1)和高剂量二甲双胍联合GLP-1组(C2)。二甲双胍低剂量用药量为0.5 g/次,每日2次口服,高剂量用药量为0.5 g/次,每日4次口服。皮下注射利拉鲁肽每日1次,起始量为每日0.6 mg,1周增加为每日1.2 mg,再1周后增加为每日1.8 mg。血糖控制在理想水平后按照标准的手术方法和规程行相应的手术治疗。同时给予饮食控制及其它对症治疗。分别在1、3、6个月时检测其股骨颈骨密度值(BMD)和Harris系统评分。结果随着治疗时间延长,A1组、C1组、C2组BMD值和Harris系统评分均增高,在术后3月和6月时,C1组骨密度值和Harris评分高于A1组(P<0.05),C1组骨密度值和Harris评分高于C2组(P<0.05)。结论胰高糖素样多肽-1可促进2型糖尿病患者骨折愈合、功能恢复,且与低剂量二甲双胍联用促进骨折愈合效果优于与高剂量二甲双胍联用。 Objective To investigate the effects of metformin and glucagon like polypeptide-1 on fracture recovery in patients with type 2 diabetes mellitus( DM). Methods We selected 120 patients with type 2 diabetes mellitus from May2016 to April 2017 in department of orthopedicsin in our hospital and randomly divided them into 5 groups,24 cases in each group,including the low dose of metformin monotherapy group( A1),the high dose of metformin monotherapy group( A2),single drug GLP-1 group( B),and GLP-1 group low dose of metformin combination( C1) and high dose of metformin combination with GLP-1 group( C2). The low dose of metformin was 0. 5 g/time,2 times a day for oral administration. The high dose was 0. 5 g/time,4 times a day. Subcutaneous injection of liraglutide was once daily,starting at a daily dose of 0. 6 mg,1. 2 mg daily after 1 week and 1. 8 mg daily after another week. After an ideal level of blood glucose control,corresponding surgical procedures should be performed according to standard surgical methods and procedures. Diet control and other symptomatic treatments were also given. The femoral neck bone mineral density( BMD) and the Harris system score were examined at the first,third,and sixth month respectively. Results With the prolongation of treatment time,the BMD value and Harris system score in the A1 group,C1 group,C2 group were increased. After surgery in March and June,the BMD and Harris score of C1 group were higher than that of A1 group( P〈0. 05). The bone mineral density and Harris score of C1 group was significantly higher than that of group C2( P〈0. 05). Conclusion Glucagon like peptide-1 may promote the fracture recovery and functional recovery in patients with type 2 diabetes mellitus,and with combination of low dose metformin is more effective than that with high dose metformin.
机构地区 东莞三局医院
出处 《广州医药》 2017年第6期33-35,47,共4页 Guangzhou Medical Journal
基金 2016年东莞市医疗卫生一般项目(201610515000974)
关键词 低剂量 高剂量 二甲双胍 胰高糖素样多肽-1 骨折愈合 Low dose High dose Metformin Glucagon like polypeptide 1 Fracture recovery
  • 相关文献

参考文献8

二级参考文献89

  • 1高虹,宁光.胰高血糖素样肽1的胰腺外作用研究进展[J].国际内科学杂志,2007,34(7):408-411. 被引量:25
  • 2Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
  • 3Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
  • 4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
  • 5Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371:1783-1789.
  • 6Pi-Sunyer X, Blackburn (3, Brancati FL, Bray GA, Bright R, Clark JM, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007; 30: 1374-1383.
  • 7Polonsky WH, Fisher L, t_iuzman S, Sleber W J, Philis-Tsimikas A, Edelman SV. Are patients' initial experiences at the diagnosis of type 2 diabetes associated with attitudes and self-management over time? Diabetes Educ 2010; 36: 828-834.
  • 8Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, et al. National Standards for diabetes self-manage- ment education. Diabetes Care 2011; 34 Suppl 1: $89-$96.
  • 9World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects - Last amended with Note of Clarification on Paragraph 29 by the WMA General Assembly, Washington 2002, and Note of Clarification on Paragraph 30 by the WMA General assembly, Tokyo 2004. http : //www, wma. net/e/policy/b 3.htm.
  • 10Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. Thethird version of the Diabetes Attitude Scale. Diabetes Care 1998; 21: 1403-1407.

共引文献111

同被引文献44

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部